NeonMind Biosciences Inc.
NeonMind Biosciences Inc.
CSE Index:
Currency:
The Issuer is engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity.
NeonMind Biosciences Inc. (NEON)
SEDAR Information
Company Info
Address
1489 Marine Drive
Unit 546
West Vancouver, BC V7T 1B8
CanadaPhone
1-705-710-6366Email
info@neonmind.comWebsite
http://www.neonmind.comListing date
Tuesday, December 29, 2020Transfer Agent
Endeavor Trust CorporationAuditor
Saturna Group Chartered Professional Accountants LLPCapitalization
Issued & Outstanding:
1,123,404Reserved for Issuance:
271,031News Releases
Bulletins
02/03/2023
2023-0306 – Consolidation - NeonMind Biosciences Inc. (NEON)
le 2 mars/March 2023
NeonMind Biosciences Inc. (the Issuer), currently halted pending a fundamental change review pursuant to CSE Policy, has completed a share consolidation on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
Advertisement
Publicité
